References
Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391–1396
Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111:659–670
Antzelevitch C (2006) Brugada syndrome. Pacin Clin Electrophysiol 29:1130–1159
Nägele H, Behrens S, Castel A (2008) Ventricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and betablocker therapy. Clin Res Cardiol 97:56–60
Veltmann C, Kuschyk J, Schimpf R, Streitner F, Schoene N, Borggrefe M, Wolpert C (2010) Prevention of inappropriate ICD shocks in patients with Brugada syndrome. Clin Res Cardiol 99:37–44
Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, Streitner F, Kuschyk J, Schimpf R, Haase KK, Borggrefe M (2005) Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2:254–260
Antz M, Berodt K, Bänsch D, Ernst S, Chun KJ, Satomi K, Schmidt B, Boczor S, Ouyang F, Kuck KH (2008) Catheter-ablation of ventricular tachycardia in patients with coronary artery disease: influence of the endocardial substrate size on clinical outcome. Clin Res Cardiol 97:110–117
Kettering K, Kampmann C, Mollnau H, Kreitner KF, Münzel T, Weiss C (2009) Catheter ablation of an incessant ventricular tachycardia originating from the left aortic sinus cusp in an adolescent with subacute myocarditis. Clin Res Cardiol 98:66–70
Lenz C, Dietze T, Möller M, Schöbel W, Wicke J, Kellner HJ, Gradaus R, Neuzner J (2009) Incessant ventricular tachycardia, refractory to catheter ablation, in an ICD patient terminated by ICD lead extraction: a case report. Clin Res Cardiol 98:803–805
Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, Dimopoulos NP, Filippatos GS, Sideris A, Kardaras F (2009) Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol 98:208–212
Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P (2000) Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome. Pacing Clin Electrophysiol 23:410–412
Dinckal MH, Davutoglu V, Akdemir I, Soydinc S, Kirilmaz A, Aksoy M (2003) Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm. Europace 5:257–261
Maury P, Hocini M, Haissaguerre M (2005) Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options. Indian Pacing Electrophysiol J 5:25–34
Ayerza MR, De Zutter M, Goethals M, Wellens F, Geelen P, Brugada P (2002) Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 13:943–944
Nakagawa E, Takagi M, Tatsumi H, Yoshiyama M (2008) Successful radiofrequency ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome. Circ J 72:1025–1029
Voss F, Bauer A, Witte S, Katus HA, Becker R (2008) Can noncontact mapping distinguish between endo- and epicardial foci? Clin Res Cardiol 97:734–741
Pagel PS, Lilly RE, Nicolosi AC (2009) Use of ECMO to temporize circulatory instability during severe Brugada electrical storm. Ann Thorac Surg 88:982–983
Maury P, Couderec P, Delay M, Boveda S, Brugada J (2004) Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace 6:130–133
Shah M, Akar FG, Tomaselli GF (2005) Molecular basis of arrhythmias. Circulation 112:2517–2529
Jongman JK, Jepkes-Bruin N, Ramdat Misier AR, Beukema WP, Delnoy PPHM, Oude Luttikhuis H, Dambrink JHE, Hoorntje JCA, Elvan A (2007) Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally. Neth Heart J 15:151–154
Joshi S, Raiszadeh F, Pierce W, Steinberg JS (2007) Antiarrhythmic induced electrical storm in Brugada syndrome: a case report. Ann Noninvasive Electrocardiol 12:274–278
Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S, Ohe T, Shimizu W (2007) Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4:701–702
Kyriazis K, Bahlmann E, van der Schalk H, Kuck KH (2009) Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram. Europace 11:665–666
Belhassen B, Glick A, Viskin S (2004) Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110:1731–1737
Mok NS, Chan NY, Chiu ACS (2004) Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 27:821–823
Michel D, Wegener JW, Nawrath H (2002) Effects of quinine and quinidine on the transient outward and on the L-type Ca2+ current in rat ventricular cardiomyocytes. Pharmacology 65:187–192
Viskin S, Antzelevitch C, Marquez MF, Belhassen B (2007) Quinidine: a valuable medication joins the list of “endangered species”. Europace 9:1105–1106
Acknowledgments
This work was supported in part by grants from the University of Heidelberg (FRONTIERS program), from the ADUMED-Foundation, and from the Max Planck Society (TANDEM program).
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schweizer, P.A., Becker, R., Katus, H.A. et al. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine. Clin Res Cardiol 99, 467–470 (2010). https://doi.org/10.1007/s00392-010-0145-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-010-0145-7